Dr. Mana Alshehri is a Senior Scientific Evaluation Expert at the Saudi Food and Drug Authority, specializing in the CMC, quality, and safety evaluation of cell and gene therapies. His experience spans academic research, pharmaceutical development, and hands-on cGMP manufacturing of cellular therapy products. He has worked at leading international institutions, including Dana-Farber Cancer Institute/Harvard University, the University of Rennes, the University of Calgary, and the University of Sheffield. He holds a PhD in Cancer Biology and several professional and executive qualifications in cellular therapies, regenerative medicine, biologics, and innovation management.